06/26/2025
9:49 AM | Haemonetics (Subject)
Llorens Josep (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2025
3:21 PM | Galvin Roy (Reporting)
Haemonetics (Issuer)
| Form 4/A | |
06/12/2025
3:51 PM | Haemonetics (Subject)
Strong Stewart W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2025
3:49 PM | Haemonetics (Issuer)
Maunsell Farris Maryanne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:17 PM | Haemonetics (Filer)
| Form DEF 14A | |
06/06/2025
3:18 PM | Haemonetics (Filer)
| Form DEFA14A | |
06/04/2025
9:06 AM | Haemonetics (Subject)
Strong Stewart W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2025
3:41 PM | Haemonetics (Issuer)
Simon, Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
3:31 PM | Basil Michelle L (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
12:16 PM | Haemonetics (Subject)
Strong Stewart W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025
3:21 PM | Haemonetics (Filer)
| Form SD
Specialized Disclosure Report | |
Get the Latest News and Ratings for HAE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Haemonetics and its competitors with MarketBeat's FREE daily newsletter. |
05/21/2025
5:12 AM | Haemonetics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
05/20/2025
4:21 PM | Galvin Roy (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
4:24 PM | Chan Frank (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
4:28 PM | Haemonetics (Issuer)
Miller Laurie A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
4:31 PM | Haemonetics (Issuer)
Maunsell Farris Maryanne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
4:10 PM | Haemonetics (Issuer)
Simon, Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
4:14 PM | DArecca James (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
4:17 PM | Basil Michelle L (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:15 PM | DArecca James (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:17 PM | Basil Michelle L (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
9:47 AM | Haemonetics (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
9:44 AM | Haemonetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/08/2025
5:03 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
3:16 PM | DArecca James (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
3:24 PM | Capital Research Global Investors (Filed by)
Haemonetics (Subject)
| Form SCHEDULE 13G/A | |
02/06/2025
5:19 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2025
5:20 AM | Haemonetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
01/14/2025
5:21 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
5:08 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
5:07 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
10:26 AM | Haemonetics (Subject)
Lingamneni Anila (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
9:41 AM | Haemonetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/07/2024
5:03 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
5:11 AM | Haemonetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
3:17 PM | Galvin Roy (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:18 PM | Haemonetics (Issuer)
Miller Laurie A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:20 PM | Haemonetics (Issuer)
Simon, Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
5:04 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
5:05 AM | Haemonetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2024
3:23 PM | Haemonetics (Filer)
| Form 8-K/A | |
The big winner of Crypto week? (Ad) It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption.
With Bitcoin hitting $123,000 and giants like BlackRock and Fidelity pouring in, one expert believes a lesser-known coin could soon be vaulted to the top — possibly even landing in the government’s digital reserve. See the coin positioned to win from Washington’s crypto push |
07/29/2024
4:03 PM | Haemonetics (Issuer)
Strong Stewart W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
3:29 PM | COYLE MICHAEL J (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
3:30 PM | Bryant Diane M (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
3:32 PM | ABERNATHY ROBERT E (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
3:34 PM | Haemonetics (Issuer)
Strong Stewart W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
3:21 PM | Haemonetics (Issuer)
Zane Ellen M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
8:47 AM | Haemonetics (Subject)
Strong Stewart W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024
3:10 PM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
